304 related articles for article (PubMed ID: 31796212)
21. Regular pre-admission urate-lowering therapy and serum urate testing are associated with a shorter hospital length of stay in people with gout: A nation-wide population-based cohort study.
Jatuworapruk K; Grainger R; Dalbeth N; Taylor WJ
Int J Rheum Dis; 2022 Feb; 25(2):154-162. PubMed ID: 34796661
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety of pegloticase in chronic gout refractory to conventional treatment.
Becker MA; Baraf HS; Yood RA; Dillon A; Vázquez-Mellado J; Ottery FD; Khanna D; Sundy JS
Ann Rheum Dis; 2013 Sep; 72(9):1469-74. PubMed ID: 23144450
[TBL] [Abstract][Full Text] [Related]
23. The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapy.
Han L; Li R; Dalbeth N; Liu M; Yu Q; Jiang C; Ning C; Liu Z; He Y; Li M; Xue X; Jia F; Jia Z; Sun W; Zhang H; Lu J; Wang C; Li C
Semin Arthritis Rheum; 2024 Aug; 67():152418. PubMed ID: 38422901
[TBL] [Abstract][Full Text] [Related]
24. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
George M; Pullman-Mooar S; Hussain F; Schumacher HR
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study.
Hu S; Sun M; Li M; Xue X; Terkeltaub R; Wang C; Wang M; Lu J; Ran Z; Li H; Ji A; Sun W; Li X; He Y; Liu Z; Zhang H; Wang X; Ji X; Dalbeth N; Li C
Rheumatology (Oxford); 2023 Jul; 62(7):2435-2443. PubMed ID: 36409036
[TBL] [Abstract][Full Text] [Related]
26. Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study.
Uhlig T; Karoliussen LF; Sexton J; Kvien TK; Haavardsholm EA; Perez-Ruiz F; Hammer HB
Clin Rheumatol; 2022 Dec; 41(12):3817-3823. PubMed ID: 36316609
[TBL] [Abstract][Full Text] [Related]
27. Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.
Peterson DM
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):402-4. PubMed ID: 21133751
[TBL] [Abstract][Full Text] [Related]
28. Gout.
Dalbeth N; Choi HK; Joosten LAB; Khanna PP; Matsuo H; Perez-Ruiz F; Stamp LK
Nat Rev Dis Primers; 2019 Sep; 5(1):69. PubMed ID: 31558729
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic approaches in the treatment of gout.
Pillinger MH; Mandell BF
Semin Arthritis Rheum; 2020 Jun; 50(3S):S24-S30. PubMed ID: 32620199
[TBL] [Abstract][Full Text] [Related]
30. An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare.
Tai V; Gow P; Stewart S; Satpanich P; Li C; Abhishek A; Dalbeth N
Semin Arthritis Rheum; 2024 Apr; 65():152367. PubMed ID: 38215627
[TBL] [Abstract][Full Text] [Related]
31. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.
Wortmann RL; Macdonald PA; Hunt B; Jackson RL
Clin Ther; 2010 Dec; 32(14):2386-97. PubMed ID: 21353107
[TBL] [Abstract][Full Text] [Related]
32. Uricosuric medications for chronic gout.
Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
[TBL] [Abstract][Full Text] [Related]
33. Initiation of febuxostat for acute gout flare does not prolong the current episode: a randomized clinical trial.
Jia E; Zhang Y; Ma W; Li B; Geng H; Zhong L; Yao X; Xie J; Xiao Y; Jiang Y; Qiu X; Xiao M; Cui X; Wei J; Zhang J
Rheumatology (Oxford); 2021 Sep; 60(9):4199-4204. PubMed ID: 33404656
[TBL] [Abstract][Full Text] [Related]
34. Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial.
Mitha E; Schumacher HR; Fouche L; Luo SF; Weinstein SP; Yancopoulos GD; Wang J; King-Davis S; Evans RR
Rheumatology (Oxford); 2013 Jul; 52(7):1285-92. PubMed ID: 23485476
[TBL] [Abstract][Full Text] [Related]
35. The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials.
Zhang X; Tang Y; Wang M; Wang D; Li Q
Clin Rheumatol; 2021 Feb; 40(2):701-710. PubMed ID: 32562072
[TBL] [Abstract][Full Text] [Related]
36. Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker.
Ea HK; Kischkel B; Chirayath TW; Klück V; Aparicio C; Loeung HU; Manivet P; Jansen T; Zarka M; Lioté F; Latourte A; Bardin T; Gauffenic A; Vicaut E; Crișan TO; Netea MG; Richette P; Joosten LA
Ann Rheum Dis; 2024 Jun; 83(7):945-956. PubMed ID: 38373842
[TBL] [Abstract][Full Text] [Related]
37. Serum urate levels and gout flares: analysis from managed care data.
Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.
He Y; Xue X; Dalbeth N; Terkeltaub R; Chen Y; Yan F; Pang L; Li X; Yuan X; Cheng X; Li C; Sun M
Arthritis Care Res (Hoboken); 2024 Jan; 76(1):131-139. PubMed ID: 37553607
[TBL] [Abstract][Full Text] [Related]
39. Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.
Schumacher HR; Sundy JS; Terkeltaub R; Knapp HR; Mellis SJ; Stahl N; Yancopoulos GD; Soo Y; King-Davis S; Weinstein SP; Radin AR;
Arthritis Rheum; 2012 Mar; 64(3):876-84. PubMed ID: 22223180
[TBL] [Abstract][Full Text] [Related]
40. Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis.
Morillon MB; Stamp L; Taylor W; Fransen J; Dalbeth N; Singh JA; Christensen R; Lassere M
BMJ Open; 2016 Sep; 6(9):e012026. PubMed ID: 27650765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
